Robert Holman, M.B.A.
Head of Finance
Senda Biosciences

Bob is the Head of Finance at Senda Biosciences and is responsible for all financial planning and analysis and accounting activities, as well as facilities and information technology. Bob has more than 20 years of experience with Boston based venture-backed technology companies.

Prior to joining Senda, Bob was the Vice President of Finance for Kintai Therapeutics, one of Senda’s predecessor companies. Bob was also the Vice President, Finance for Seven Bridges Genomics, where he led the Finance team as the company tripled its workforce and completed a successful biotech spin-out, Totient. He also worked at PatientsLikeMe serving as Vice President of Finance, where he led significant equity transactions and re-engineered internal operations while the company pivoted to build out its research capabilities.

Bob holds an MBA from Babson College – Franklin W. Olin School of Business and a BA in Accounting from Merrimack College.